3020 Children's Way
San Diego, CA 92123
Rady Children's Specialists of San Diego
Rady Children's Specialists
Sackler School of Medicine
Brown University School of Medicine
Brown University School of Medicine
Children's Hospital Los Angeles
Pediatric Hematology/Oncology, Pediatrics
Dr. William Roberts is the chief of the Division of Hematology/Oncology in the UC San Diego Department of Pediatrics and the medical director of the Peckham Center for Cancer & Blood Disorders at Rady Children's Hospital-San Diego. He is also vice president and medical director of the Rady Children's Specialists San Diego (RCSSD) medical group and a clinical professor of pediatrics at UC San Diego School of Medicine.
Dr. Roberts serves as the principal investigator for the UC San Diego/Rady Children's Children's Oncology Group Program and the Neuroblastoma & Medulloblastoma Translational Research Consortium. He started the UC San Diego/Rady Children's Pediatric Hematology/Oncology Fellowship Program and served as the fellowship program director from 2007 to 2015.
Additionally, Dr. Roberts is a member of the UC San Diego Moores Cancer Center and serves as the Pediatric Disease Team chairperson, is a member of the Rady Children's Medical Staff Executive Committee, and is the chairperson of the Hematology/Oncology Morbidity & Mortality Committee. He serves on the Children's Specialists of San Diego Board of Directors and Executive Board of Directors, as well as the RCSSD Medical Practice Foundation Board of Governance Committee.
Dr. Roberts is also working with the Twinning Program of Rady Children's and the General Hospital of Tijuana, Mexico, in developing the Pediatric Oncology Program at the General Hospital.
In 2015, he received Rady Children's Excellence in Clinical Care Award. Dr. Roberts has worked at Rady Children's since 1992.
Feasibility Of Implementing Molecular-Guided Therapy For The Treatment Of Patients With Relapsed Or Refractory Neuroblastoma
Saulnier Sholler GL, Bond JP, Bergendahl G, Dutta A, Dragon J, Neville K, Ferguson W, Roberts W, Eslin D, Kraveka J, Kaplan J, Mitchell D, Parikh N, Merchant M, Ashikaga T, Hanna G, Lescault PJ, Siniard A, Corneveaux J, Huentelman M, Trent J
Identification Of Drug Combinations Containing Imatinib For Treatment Of BCR-ABL+ Leukemias
Kang Y, Hodges A, Ong O, Roberts W, Piermarocchi C, Paternostro G
Genomic Ancestry And Somatic Alterations Correlate With Age At Diagnosis In Hispanic Children With B-cell Acute Lymphoblastic Leukemia
Walsh KM, de Smith AJ, Welch TC, Smirnov I, Cunningham MJ, Ma X, Chokkalingam AP, Dahl GV, Roberts W, Barcellos LF, Buffler PA, Metayer C, Wiemels JL
Fit4Life: A Weight Loss Intervention For Children Who Have Survived Childhood Leukemia
Huang JS, Dillon L, Terrones L, Schubert L, Roberts W, Finklestein J, Swartz MC, Norman GJ, Patrick K
Metabolomics Of The Tumor Microenvironment In Pediatric Acute Lymphoblastic Leukemia
Tiziani S, Kang Y, Harjanto R, Axelrod J, Piermarocchi C, Roberts W, Paternostro G
GATA3 Risk Alleles Are Associated With Ancestral Components In Hispanic Children With ALL
Walsh KM, de Smith AJ, Chokkalingam AP, Metayer C, Roberts W, Barcellos LF, Wiemels JL, Buffler PA
Metabolomic High-Content Nuclear Magnetic Resonance-Based Drug Screening Of A Library Of Kinase Inhibitors
Tiziani S, Kang Y, Choi J, Roberts W, Paternostro G
Combination of Gemcitabine And Docetaxel In Treatment Of Children And Young Adults With Refractory Bone And Soft Tissue Sarcoma
Navid F, Willert JR, McCarville B, Furman W, Watkins A, Roberts W, Daw NC